The global Apheresis Market was valued at USD 1.37 billion in 2016 and is projected to reach USD 2.64 billion by 2025, growing at a CAGR of 7.56% from 2017 to 2025.
Apheresis is a medical technology in which the blood of a person is passed through an apparatus that separates out one particular constituent and returns the remainder to the circulation. The market is growing because of number of key drivers, injuries and trauma increments being one of them.
Sample Infographics:
Market Dynamics:
1. Market Drivers
1.1 Increasing number of injuries and Trauma cases
1.2 Increasing demands from biopharmaceutical companies for Plasma sources
1.3 Increasing demand of blood transfusions and blood safety concerns
1.4 Increasing complex surgical procedures
1.5 Favorable reimbursements
2. Market Restraints
2.1 Lack of information about Apheresis
2.2 High Cost of the devices
2.3 Lack of Qualified Donors
Market Segmentation:
1. Global Apheresis Market, by Application:
1.1 Plasmapheresis
1.2 Plateletpheresis
1.3 Erythrocytapheresis
1.4 Leukapheresis
1.5 Other Applications
2. Global Apheresis Market, by Technology:
2.1 Centrifugation
2.1.1 Intermittent Flow
2.1.2 Continuous Flow
2.2 9.3 Membrane Separation
3. Global Apheresis Market, by Product:
3.1 Apheresis Devices
3.1.1 Plasma Separators
3.1.2 Plasma Component Separators
3.1.3 Immunoadsorption Columns
3.1.4 Plasma Perfusion Columns
3.1.5 Hemoperfusion Columns
3.2 8.3 Apheresis Disposables
4. Global Apheresis Market, by Procedure:
4.1 Automated/Apheresis Blood Collection (Donor Apheresis)
4.2 Therapeutic Apheresis
4.2.1 Therapeutic Apheresis Market, By Disease
4.2.1.1 Neurological Disorders
4.2.1.2 Blood Disorders
4.2.1.3 Cardiovascular Disorders
4.2.1.4 Renal Disorders
4.2.1.5 Autoimmune Disorders
4.2.1.6 Metabolic Disorders
4.2.1.7 Other Disorders
4.3 Therapeutic Apheresis Market, By Procedure:
4.3.1 Therapeutic Plasma Exchange (TPE)
4.3.2 Therapeutic Cytapheresis
4.3.2.1 Therapeutic Erythrocytapheresis
4.3.2.2 Therapeutic Plateletphersis
4.3.2.3 Leukapheresis
4.3.3 Photopheresis
4.3.4 Extracorporeal Immunoadsorption (ECI)
5. Global Apheresis Market, by Region:
5.1 North America (U.S., Canada, Mexico)
5.2 Europe (Germany, UK, France, Rest of Europe)
5.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
5.4 Latin America (Brazil, Argentina, Rest of Latin America)
5.5 Middle East & Africa
Competitive Landscape:
The major players in the market are as follows:
1. Cerus Corporation
2. Fresenius SE & Co. KGaA
3. Asahi Kasei Medical Co., Ltd. (A Subsidiary of Asahi Kasei Corporation)
4. Haemonetics Corporation
5. Terumo BCT, Inc.
6. Hemacare Corporation
7. B. Braun Melsungen AG
8. Kaneka Corporation
9. Kawasumi Laboratories Inc.
10. Nikkiso Co., Ltd.
These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.
RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE:
Research study on the Apheresis Market was performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.
The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.
To know more about the Research Methodology of Verified Market Intelligence and other aspects of the research study, kindly get in touch with our sales team.
1 INTRODUCTION OF GLOBAL APHERESIS MARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources
4 GLOBAL APHERESIS MARKET OUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework
5 GLOBAL APHERESIS MARKET, BY APPLICATION
5.1 Plasmapheresis
5.2 Plateletpheresis
5.3 Erythrocytapheresis
5.4 Leukapheresis
5.5 Other Applications
6 GLOBAL APHERESIS MARKET, BY TECHNOLOGY
6.1 Centrifugation
6.1.1 Intermittent Flow
6.1.2 Continuous Flow
6.2 Membrane Separation
7 GLOBAL APHERESIS MARKET, BY PRODUCT
7.1 Apheresis Devices
7.1.1 Plasma Separators
7.1.2 Plasma Component Separators
7.1.3 Immunoadsorption Columns
7.1.4 Plasma Perfusion Columns
7.1.5 Hemoperfusion Columns
7.2 Apheresis Disposables
8 GLOBAL APHERESIS MARKET, BY PROCEDURE
8.1 Automated/Apheresis Blood Collection (Donor Apheresis)
8.2 Therapeutic Apheresis
8.2.1 Therapeutic Apheresis Market, By Disease
8.2.1.1 Neurological Disorders
8.2.1.2 Blood Disorders
8.2.1.3 Cardiovascular Disorders
8.2.1.4 Renal Disorders
8.2.1.5 Autoimmune Disorders
8.2.1.6 Metabolic Disorders
8.2.1.7 Other Disorders
8.3 Therapeutic Apheresis Market, By Procedure:
8.3.1 Therapeutic Plasma Exchange (TPE)
8.3.2 Therapeutic Cytapheresis
8.3.2.1 Therapeutic Erythrocytapheresis
8.3.2.2 Therapeutic Plateletphersis
8.3.2.3 Leukapheresis
8.3.3 Photopheresis
8.3.4 Extracorporeal Immunoadsorption (ECI)
9 GLOBAL APHERESIS MARKET, BY GEOGRAPHY
9.1 Overview
9.2 North America Regional Market Estimates and Forecasts, 2012 - 2025
9.2.1 U.S.
9.2.2 Canada
9.2.3 Mexico
9.3 Europe Regional Market Estimates and Forecasts, 2012 - 2025
9.3.1 Germany
9.3.2 U.K.
9.3.3 France
9.3.4 Rest of Europe
9.4 Asia Pacific Regional Market Estimates and Forecasts, 2012 - 2025
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Rest of Asia Pacific
9.5 Latin America Regional Market Estimates and Forecasts, 2012 - 2025
9.5.1 Brazil
9.5.2 Argentina
9.6 Rest of the World Regional Market Estimates and Forecasts, 2012 â€" 2025
10 GLOBAL APHERESIS MARKETCOMPETITIVE LANDSCAPE
10.1 Overview
10.2 Company Market Share
10.3 Vendor Landscape
10.4 Key Development Strategies
11 COMPANY PROFILES
11.1 Cerus Corporation
11.1.1 Overview
11.1.2 Financial Performance
11.1.3 Product Outlook
11.1.4 Key Developments
11.2 Fresenius SE & Co. KGaA
11.2.1 Overview
11.2.2 Financial Performance
11.2.3 Product Outlook
11.2.4 Key Developments
11.3 Asahi Kasei Medical Co., Ltd.
11.3.1 Overview
11.3.2 Financial Performance
11.3.3 Product Outlook
11.3.4 Key Developments
11.4 Haemonetics Corporation
11.4.1 Overview
11.4.2 Financial Performance
11.4.3 Product Outlook
11.4.4 Key Developments
11.5 Terumo BCT, Inc.
11.5.1 Overview
11.5.2 Financial Performance
11.5.3 Product Outlook
11.5.4 Key Developments
11.6 Hemacare Corporation
11.6.1 Overview
11.6.2 Financial Performance
11.6.3 Product Outlook
11.6.4 Key Developments
11.7 B. Braun Melsungen AG
11.7.1 Overview
11.7.2 Financial Performance
11.7.3 Product Outlook
11.7.4 Key Developments
11.8 Kaneka Corporation
11.8.1 Overview
11.8.2 Financial Performance
11.8.3 Product Outlook
11.8.4 Key Developments
11.9 Kawasumi Laboratories Inc.
11.9.1 Overview
11.9.2 Financial Performance
11.9.3 Product Outlook
11.9.4 Key Developments
11.10 Nikkiso Co., Ltd.
11.10.1 Overview
11.10.2 Financial Performance
11.10.3 Product Outlook
11.10.4 Key Developments
12 Appendix
12.1 Related Reports